>
Fa   |   Ar   |   En
   Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma  
   
نویسنده he g. ,zhang h. ,zhou j. ,wang b. ,chen y. ,kong y. ,xie x. ,wang x. ,fei r. ,wei l. ,chen h. ,zeng h.
منبع journal of experimental and clinical cancer research - 2015 - دوره : 34 - شماره : 1
چکیده    Background: pd-l1 expression on neutrophils contributes to the impaired immune response in infectious disease,but the detailed role of pd-l1 expression on neutrophils in hcc remains unclear. methods: we investigated the phenotype and morphology of neutrophils infiltrated in tumour tissues from both patients with hcc and hepatoma-bearing mice. results: we found that neutrophils dominantly infiltrated in the peritumoural region. the neutrophil-to-t cell ratio (nlr) was higher in peritumoural tissue than that in the intratumoural tissue and was negatively correlated with the overall survival of patients with hcc. infiltrating neutrophils displayed a phenotype of higher frequency of programmed cell death ligand 1 (pd-l1) positive neutrophils. the ratio of pd-l1+ neutrophils-to-pd-1+ t cells was higher in peritumoural tissue and better predicted the disease-free survival of patients with hcc. we further confirmed a higher frequency of pd-l1+ neutrophils and pd-1+ t cells in hepatoma-bearing mice. functionally,the pd-l1+ neutrophils from patients with hcc effectively suppressed the proliferation and activation of t cells,which could be partially reversed by the blockade of pd-l1. conclusions: our results indicate that the tumour microenvironment induces impaired antitumour immunity via the modulation of pd-l1 expression on tumour infiltrating neutrophils. © 2015 he et al.
کلیدواژه Hepatocellular carcinoma; Neutrophils; Predictive Value; Programmed death ligand 1
آدرس peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044,china,institute of infectious diseases,beijing ditan hospital,capital medical university,beijing,100015,china,beijing key laboratory of emerging infectious diseases,beijing,100015, China, department of hepatobiliary and pancreatic surgery,henan tumour hospital,zhengzhou,henan 450008, China, institute of infectious diseases,beijing ditan hospital,capital medical university,beijing,100015,china,beijing key laboratory of emerging infectious diseases,beijing,100015, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, institute of infectious diseases,beijing ditan hospital,capital medical university,beijing,100015,china,beijing key laboratory of emerging infectious diseases,beijing,100015, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, peking university people's hospital,peking university hepatology institute,no.11 xizhimen south street,beijing,100044,china,beijing key laboratory of hepatitis c and immunotherapy for liver diseases,beijing,100044, China, institute of infectious diseases,beijing ditan hospital,capital medical university,beijing,100015,china,beijing key laboratory of emerging infectious diseases,beijing,100015, China
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved